Dr. Kenneth Broadley

Dr. Kenneth Broadley has an extensive work experience in the field of regulatory affairs, quality assurance, and new product development. Dr. Kenneth started their career at Johnson & Johnson Medical Biopolymer Group in 1992 as a Manager of Pre-Clinical Research. Dr. Kenneth later joined Henkel in 1998 as a Manager of Biomedical Product Development, where they worked until 2014. In 2015, Dr. Broadley joined Chemence Medical, Inc. as Vice President of Regulatory Affairs, Quality Assurance, and New Product Development. Dr. Kenneth then became the Executive Vice President from March 2016 to October 2021. Dr. Kenneth joined Chemence in 2019 as the Chief Regulatory and Quality Officer. Currently, Dr. Broadley is with IFS Industries, Inc. as the Vice President of Product and Regulatory Affairs.

Dr. Kenneth Broadley obtained a Bachelor of Science (BS) and a PhD in Cell Biology from the University of Glasgow, starting in 1977.